During the past decade, Kuwait Cancer Control Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kuwait Cancer Control Center" are "Drug Use for Unapproved Schedule" (1 trials), "Locally Advanced Head and Neck Cancer" (1 trials) and "Nasopharyngeal Carcinoma" (1 trials). Many other conditions were trialed in "Kuwait Cancer Control Center" in a lesser frequency.

Most popular intervention types in "Kuwait Cancer Control Center" are "Drug" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acyclovir 800 MG" (1 trials), "Gemcitabin/cisplatin" (1 trials), "Pembrolizumab" (1 trials) and "Radiotherapy and chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kuwait Cancer Control Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kuwait Cancer Control Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kuwait Cancer Control Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kuwait Cancer Control Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".